NAF1 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.49970036389391E-10 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.61359999995003E-06 |
Normal-vs-Stage2 |
1.458150E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.731740E-02 |
Stage1-vs-Stage2 |
5.095800E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
9.541400E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
6.734800E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.46390000121954E-08 |
Normal-vs-AfricanAmerican |
1.610170E-01 |
Normal-vs-Asian |
1.67529999983707E-07 |
Caucasian-vs-AfricanAmerican |
4.597800E-01 |
Caucasian-vs-Asian |
1.609830E-01 |
AfricanAmerican-vs-Asian |
5.533800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.010200E-04 |
Normal-vs-Female |
1.59880000349943E-08 |
Male-vs-Female |
2.350800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
6.599400E-03 |
Normal-vs-Extreme_Weight |
5.74749999999735E-05 |
Normal-vs-Obese |
2.202800E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
6.977600E-01 |
Normal_Weight-vs-Obese |
4.001400E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
1.431810E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.355800E-01 |
Normal-vs-Age(41-60Yrs) |
1.020790E-03 |
Normal-vs-Age(61-80Yrs) |
5.06589999949014E-08 |
Normal-vs-Age(81-100Yrs) |
7.578600E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.239800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.880800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.290800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.793200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.125200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.189800E-02 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
1.421770E-01 |
Normal-vs-Grade 3 |
6.534200E-02 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
5.031600E-01 |
Grade 2-vs-Grade 4 |
1.421770E-01 |
Grade 3-vs-Grade 4 |
6.534200E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
8.82530000190229E-08 |
Normal-vs-N1 |
1.337660E-02 |
N0-vs-N1 |
3.008600E-01 |
|
|